HighCape Capital Acquisition Corp.
Completed 2021-06-10- CIK 1816431
- CAPA
- Now QSI
- IPO 2020-09-04
- $115M trust
- 471 filings
Successfully merged with Quantum-Si Incorporated • Now trading as QSI
- IPO Size
- $115M
- raised at the IPO
- Trust
- $115M
- as of 2021-03-31
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2020
- year it listed
Filings, by quarter
471 filings over 26 quarters; violet bars carry a milestone
- 20 Q3: 22 filings
- 20 Q4: 3 filings
- 21 Q1: 14 filings
- 21 Q2: 63 filings
- 21 Q3: 17 filings
- 21 Q4: 5 filings
- 22 Q1: 29 filings
- 22 Q2: 29 filings
- 22 Q3: 8 filings
- 22 Q4: 10 filings
- 23 Q1: 21 filings
- 23 Q2: 19 filings
- 23 Q3: 17 filings
- 23 Q4: 2 filings
- 24 Q1: 18 filings
- 24 Q2: 27 filings
- 24 Q3: 13 filings
- 24 Q4: 13 filings
- 25 Q1: 21 filings
- 25 Q2: 20 filings
- 25 Q3: 16 filings
- 25 Q4: 22 filings
- 26 Q1: 18 filings
- 26 Q2: 30 filings
- 26 Q3: 12 filings
- 26 Q4: 2 filings
- S-1 filed 20 Q3
- IPO 20 Q3
- Definitive agreement 21 Q1
- Completed 21 Q2
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
HighCape Capital Acquisition Corp. is a blank-check company seeking to complete a business combination, with an intended focus across the life sciences industry, including therapeutics, devices, diagnostics, medical information technology, agrisciences and animal health.
Investment Focus
Healthcare, Biopharmaceuticals, Agriculture
Key Information
As the filings state it
- IPO Date
- 2020-09-04
- Total Redemptions
- $5.7M
- PIPE
- $425M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2021-06-10
- Merger Target
- Quantum-Si Incorporated
- SPAC Ticker
- CAPA
- Merged Ticker
- QSI
Stock Performance
QSITrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2020-11-13 | $9.88 | |
| At Merger | 2021-06-11 | $9.75 | -1% |
| 6 Months Post-Merger | 2021-12-13 | $6.01 | -38% |
| 1 Year Post-Merger | 2022-06-13 | $2.97 | -70% |
| 2 Years Post-Merger | 2023-06-12 | $1.61 | -83% |
| Current Price | 2026-10-16 | $1.12 | -89% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team is led by Kevin Rakin and Matt Zuga, HighCape co-founders with decades of life-sciences investing and operating experience; its independent directors bring experience across biopharmaceuticals, medical devices, business development and company leadership.